Basics Sagimet Biosciences Inc. Series A IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $231.23M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 5.04% Avg Daily Range (30 D): $0.31 | 3.64% Avg Daily Range (90 D): $0.33 | 4.88% Institutional Daily Volume Avg Daily Volume: .77M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): 1.17M Trade Size Avg Trade Size (Sh.): 128 Avg Trade Size (Sh.) (30 D): 106 Avg Trade Size (Sh.) (90 D): 121 Institutional Trades Total Inst.Trades: 60 Avg Inst. Trade: $1.35M Avg Inst. Trade (30 D): $.54M Avg Inst. Trade (90 D): $.78M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.63M Avg Closing Trade (30 D): $.52M Avg Closing Trade (90 D): $.74M Avg Closing Volume: 465.98K     News Aug 5, 2025 @ 11:00 AM Sagimet Biosciences to Participate in the Canaccor... Source: Sagimet Biosciences Jun 9, 2025 @ 11:00 AM Sagimet Biosciences to Host Virtual KOL Event, ââ... Source: N/A Oct 1, 2024 @ 4:05 AM Sagimet Biosciences to Present at the H.C. Wainwri... Source: N/A Jun 6, 2024 @ 9:00 AM Sagimet Biosciences Presents Data from ITT and F3 ... Source: Sagimet Biosciences Inc. May 16, 2024 @ 12:20 PM Alibaba To Rally Over 13%? Here Are 10 Top Analyst... Source: Avi Kapoor Financials   TTM Q4 2024 FY 2024 Basic EPS $-.56 $-.5 $-1.45 Diluted EPS $-.56 $-.5 $-1.45 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -18.18M $ -16.2M $ -45.57M Operating Income / Loss $ -19.87M $ -18.2M $ -54.45M Cost of Revenue $ $ $ Net Cash Flow $ M $ -1.17M $ .7M PE Ratio